Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 1 of 1 entries
Sorted by: Best Match Show Resources per page
ANTI-IL-2 Receptor Antibody Treatment for Lymphoproliferative Disease: Transient Response in A Case of Ki-1+ Anaplastic Large Cell Lymphoma.

Leukemia & lymphoma

Emilie D, Peuchmaur M, Solal-Celigny P, Boue F, Defraissy JF, Tertian G, Dormont J, Galanaud P.
PMID: 27464248
Leuk Lymphoma. 1991;3(4):277-85. doi: 10.3109/10428199109107915.

Most cases of Ki-1 + anaplastic large cell lymphomas (ALCL) express the CD25 antigen, and we have recently shown that IL-2 producing cells can also be detected in these lymphomas. The latter cells may thus constitute targets for anti-CD25...

Cite
Emilie D, Peuchmaur M, Solal-Celigny P, et al. ANTI-IL-2 Receptor Antibody Treatment for Lymphoproliferative Disease: Transient Response in A Case of Ki-1+ Anaplastic Large Cell Lymphoma. Leuk Lymphoma. 1991;3(4):277-85doi: 10.3109/10428199109107915.
Emilie, D., Peuchmaur, M., Solal-Celigny, P., Boue, F., Defraissy, J. F., Tertian, G., Dormont, J., & Galanaud, P. (1991). ANTI-IL-2 Receptor Antibody Treatment for Lymphoproliferative Disease: Transient Response in A Case of Ki-1+ Anaplastic Large Cell Lymphoma. Leukemia & lymphoma, 3(4), 277-85. https://doi.org/10.3109/10428199109107915
Emilie, D, et al. "ANTI-IL-2 Receptor Antibody Treatment for Lymphoproliferative Disease: Transient Response in A Case of Ki-1+ Anaplastic Large Cell Lymphoma." Leukemia & lymphoma vol. 3,4 (1991): 277-85. doi: https://doi.org/10.3109/10428199109107915
Emilie D, Peuchmaur M, Solal-Celigny P, Boue F, Defraissy JF, Tertian G, Dormont J, Galanaud P. ANTI-IL-2 Receptor Antibody Treatment for Lymphoproliferative Disease: Transient Response in A Case of Ki-1+ Anaplastic Large Cell Lymphoma. Leuk Lymphoma. 1991;3(4):277-85. doi: 10.3109/10428199109107915. PMID: 27464248.
Copy Download .nbib Format: NLM
Showing 1 to 1 of 1 entries